Pashtoon Kasi: FDA Expands Access to DaraxonRASib for Pancreatic Cancer
Pashtoon Kasi/X

Pashtoon Kasi: FDA Expands Access to DaraxonRASib for Pancreatic Cancer

Pashtoon Kasi, Medical Director of GI Medical Oncology at City of Hope Orange County, shared a post on X:

US FDA and the scientific community – one of the most common questions I get weekly:

When will the ‘revolutionary’ DaraxonRASib be available?

My answer:

This year – one way or another.

You delivered. Patients can’t wait!”

Watch the video

Other articles featuring Pashtoon Kasi on OncoDaily.